On Tuesday, Senti Biosciences, Inc. (NASDAQ:SNTI) shared new data from its ongoing trial of SENTI-202, a first-in-class CD33/FLT3 targeting Logic Gated CAR NK cell therapy in patients with relapsed or refractory Acute Myeloid Leukemia. Senti Biosciences shares are retreating from…
Elon Musk‘s satellite internet company Starlink clarified Monday that subscription fees for its service in India have not been set and orders are not open, following a brief website glitch that showed dummy pricing. The company’s website earlier showed a…
Dyne Therapeutics, Inc. (NASDAQ:DYN) on Monday revealed topline results from the Registrational Expansion Cohort (REC) of its Phase 1/2 DELIVER trial evaluating zeleciment rostudirsen (z-rostudirsen, also known as DYNE-251) for Duchenne muscular dystrophy (DMD) amenable to exon 51 skipping. The…
Ocular Therapeutix Inc. (NASDAQ:OCUL) stock surged on Monday after the company announced plans to accelerate the timeline for submitting a New Drug Application (NDA) for Axpaxli (OTX-TKI) in the treatment of wet age-related macular degeneration (wet AMD). The company intends…
Eli Lilly and Co. (NYSE:LLY) announced that its diabetes drug, Mounjaro, will be added to China’s state-run health insurance scheme from January 1, 2026. Mounjaro Added to China Reimbursement List The inclusion of Mounjaro on China’s national reimbursement list, as decided by its…
Praxis Precision Medicines Inc. (NASDAQ:PRAX) stock rose Friday after the company shared results from the registrational cohort of the EMBOLD study evaluating relutrigine for the treatment of patients with SCN2A and SCN8A developmental and epileptic encephalopathies (DEEs). The Data Monitoring…
The U.S. Food and Drug Administration (FDA) placed a clinical hold on Denali Therapeutics Inc.’s (NASDAQ:DNLI) investigational new drug (IND) application for the Phase 1 study of DNL952 under development for Pompe disease. The FDA requested a protocol amendment to…
The U.S. Food and Drug Administration (FDA) in December issued a safety alert urging people with diabetes to stop using select glucose sensors made by Abbott Laboratories’ (NYSE:ABT) Diabetes Care, after the company linked the devices to seven deaths and…
On Thursday, the U.S. Food and Drug Administration (FDA) approved Bristol Myers Squibb & Co.’s (NYSE:BMY) Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T cell therapy, for adult patients with relapsed or refractory (R/R) marginal zone lymphoma…
Praxis Precision Medicines Inc. (NASDAQ:PRAX) shares surged 24.81% in pre-market trading on Friday, climbing to $237.10. Check out the current price of PRAX stock here. PRAX closed Thursday's regular session at $189.97, up 2.05%, according to Benzinga Pro data. Early…